Definitive Contract 75N91021C00020
Award Date
9/16/21
Potential Completion Date
6/15/22
Potential Value
$400K
Federal Agency
National Cancer Institute
Awardee
Care Progress LLC
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chevy Chase, MD 20815, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
5
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $2,299,737 Definitive Contract awarded by the National Cancer Institute, a component of the National Institutes of Health, to Care Progress LLC, a small business, to develop financial navigation tools that enable cancer providers and patients to make informed choices and minimize the financial hardship associated with cancer care. The contract was competitively awarded as a Small Business Innovation Research (SBIR) Phase I Fast Track program, with an ultimate completion date of...
The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $1,724,411.00 Firm Fixed Price, Phase I Small Business Innovation Research (SBIR) contract to Care Progress LLC, a for-profit limited liability company. The contract is for the development of digital platforms to support informal cancer caregiving, connecting cancer caregivers to care teams. Care Progress LLC has previous experience in developing participant engagement platforms for...
This federal contract was awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Care Progress LLC, a for-profit small business, to develop technology solutions to improve long-term care for cancer survivors under the Cancer Moonshot initiative. The $224,875 Firm Fixed Price contract was a Small Business Innovation Research (SBIR) Phase I award, with a completion date of June 15, 2020. Care Progress LLC has previously received other...
This $399,987 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Cancer Institute (NCI), a part of the National Institutes of Health (NIH), to Care Progress LLC, a small business limited liability company. The contract supports the development of cancer clinical trials recruitment and retention tools for participant engagement, as described in the original SBIR solicitation. The solicitation sought proposals for SBIR Phase I and Phase II contracts to conduct...
This is a federal contract awarded by the National Cancer Institute (NCI), a civilian agency, to Pointcare Genomics Corp, a small minority-owned business, for research and development in biomedical basic research. The contract is a definitive, firm-fixed price contract valued at $299,961.00 and is part of the SBIR (Small Business Innovation Research) Program Phase I. The contract has a total small business set-aside designation and was awarded on September 22, 2015, with a completion date of...
<p>This is a $299,999.00 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian agency, to Innogenomics Technologies, L.L.C., a minority-owned small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for research and development in the area of biomedical (basic research). It was awarded on September 22, 2015 with a final completion date of March 21, 2017. The contract has a total small business set-aside designation.</p>
This is a $300,000 Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a civilian agency, to Coordination Pharmaceuticals Inc., a small business. The contract is for the detection, diagnosis, treatment, prevention, and research of pediatric cancers and/or rare cancers. It was awarded under a Small Business Innovation Research (SBIR) Concept Award Program, which is a "Phase 0" pilot program intended to encourage small businesses to develop innovative and...
The National Cancer Institute (NCI) awarded a Firm Fixed Price Definitive Contract to Navipoint Genomics LLC, a minority-owned small business, under the SBIR Program Phase II. The contract, valued at $1,679,321.00, is for the development of cloud-based software to support the Cancer Research Data Commons project. This project aims to enable precision oncology by facilitating collaboration in the cloud. The contract has a completion date of May 31, 2025 and is set aside for small businesses.
<p>The National Cancer Institute (NCI), a civilian federal agency, awarded a $1,416,758.40 Cost Plus Fixed Fee contract to Sensopath Technologies, Inc., a Woman Owned Small Business, for a Small Business Innovation Research (SBIR) Program Phase II action. The contract, which has a total small business set aside, was awarded on September 28, 2012 with an ultimate completion date of May 22, 2015. The contract delivers research and development services under the SBIR program.</p>
This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Pieces Technologies Inc., a small business, under the Small Business Innovation Research (SBIR) Phase II program. The contract, worth $1,999,994.00, is for the project titled "Passive and Active AI Screening for Social Determinants of Health and Interventions to Improve Outcomes in the Cancer Patient Population." The contract has a period of performance from September 16,...